A share price of Renalytix Plc ADR [RNLX] is currently trading at $0.39, down -7.27%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RNLX shares have gain 9.59% over the last week, with a monthly amount glided 54.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Renalytix Plc ADR [NASDAQ: RNLX] stock has seen the most recent analyst activity on January 18, 2022, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $30. Previously, BTIG Research started tracking the stock with Buy rating on January 04, 2022, and set its price target to $24. On October 04, 2021, Guggenheim initiated with a Buy rating and assigned a price target of $28 on the stock. Berenberg started tracking the stock assigning a Buy rating and suggested a price target of $38 on July 02, 2021. Stifel initiated its recommendation with a Buy.
Renalytix Plc ADR experienced fluctuations in its stock price throughout the past year between $0.22 and $3.14. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Renalytix Plc ADR [NASDAQ: RNLX] shares were valued at $0.39 at the most recent close of the market. An investor can expect a potential return of 412.82% based on the average RNLX price forecast.
Analyzing the RNLX fundamentals
Trailing Twelve Months sales for Renalytix Plc ADR [NASDAQ:RNLX] were 2.22M which represents -26.10% decline. Gross Profit Margin for this corporation currently stands at -0.02% with Operating Profit Margin at -14.99%, Pretax Profit Margin comes in at -16.87%, and Net Profit Margin reading is -16.88%. To continue investigating profitability, this company’s Return on Assets is posted at -4.27, Equity is 11.03 and Total Capital is 5.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3281 points at the first support level, and at 0.2711 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4261, and for the 2nd resistance point, it is at 0.4671.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Renalytix Plc ADR [NASDAQ:RNLX] is 0.42. In addition, the Quick Ratio stands at 0.42 and the Cash Ratio stands at 0.31. Considering the valuation of this stock, the price to sales ratio is 14.39.
